Abstract: Apparatuses, systems, and techniques of using one or more circuits (e.g., of a network interface) to obtain contents of at least one memory region usable, by one or more processes being performed by a host computing system, to store dynamic memory allocations, and determine whether any of the process(es) is performing at least one potentially harmful task based at least in part on the contents of the memory region(s).

Abstract: Apparatuses, systems, and techniques of using one or more circuits (e.g., of a network interface) to obtain assembly code for one or more machine code segments loaded and/or injected into a process, and determine whether the assembly code is likely to perform at least one unauthorized task.

Abstract: A two-phase immersion cooling system for an integrated circuit assembly may be formed utilizing boiling enhancement structures formed on or directly attached to heat dissipation devices within the integrated circuit assembly, formed on or directly attached to integrated circuit devices within the integrated circuit assembly, and/or conformally formed over support devices and at least a portion of an electronic board within the integrated circuit assembly. In still a further embodiment, the two-phase immersion cooling system may include a low boiling point liquid including at least two liquids that are substantially immiscible with one another.

Abstract: Apparatus for performing a procedure at a target site of a patient's body, the apparatus comprising: a continuous positive airway pressure (CPAP) apparatus that provides CPAP to the patient's lungs; a medical device for performing the procedure at the target site; and a controller that controls the CPAP apparatus to provide CPAP to the patient's lungs during performance of the procedure.

Abstract: The present invention provides a unique profile of volatile organic compounds as breath biomarkers for lung cancer. The present invention further provides the diagnosis, prognosis and monitoring of lung cancer or predicting the response to an anti-cancer treatment through the detection of the unique profile of volatile organic compounds indicative of lung cancer at its various stages.

Abstract: Apparatus for performing a procedure at a target site of a patient's body, the apparatus comprising: a continuous positive airway pressure (CPAP) apparatus that provides CPAP to the patient's lungs; a medical device for performing the procedure at the target site; and a controller that controls the CPAP apparatus to provide CPAP to the patient's lungs during performance of the procedure.

Abstract: The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.

Abstract: The present invention provides methods of identifying a genetic abnormality such as mutation in EGFR or KRAS or ALK which is associated with the management of lung cancer or diagnosing, prognosing or monitoring the treatment of pre-cancerous conditions of the lung, such as bronchial dysplasia or atypical alveolar hyperplasia (AAH), through the detection of at least one volatile organic compound indicative of these states.

Abstract: The present invention provides pharmaceutical compositions comprising a flumazenil, and methods of alleviating or counteracting residual effects (e.g. drowsiness) associated with the administration of sleep/hypnotic drugs or alleviating effects of alcohol intoxication, using self administration modes of delivery.